Genoxy
Natural, Nontoxic Technology for Eliminating Antibiotic Resistant Bacteria from Surfaces
Startup Pre-Funding Health Tech & Life Sciences Est. 2021
Total Raised
Undisclosed
Pre-Funding
Last Round
Undisclosed
Team
1
1-10 employees
Confidence
87/100
Patents
1
About
Genoxy is developing a patented, natural, nontoxic method of disinfecting drug-resistant bacteria from surfaces, using the bio-conversion of water into hydrogen peroxide. The device is a desktop convertor, with a jet technology hand piece that breaks the liquid into micro-droplets. The sprayed liquid ensures complete surface coverage, with no need to wipe after application. Genoxy's objectives are to save lives and make the supply chain more efficient by reducing material and labor costs.
Classification
Sector
Industrial TechnologiesMaterial Innovations & Applications
Core Technology
Materials & Substances
Target Customer
Healthcare & Life SciencesHealthcareProviders
Business Model
B2B
Tags
hospitalsbiotechnologyantibioticssurface-and-coatingspublic-safetymedical-devices
Details
Product Stage
R&D
Employees
1-10
Exact Count
3
District
North District
Founded
2021
Locations
Qatsrin
Links
Website
LinkedIn
Admin
Last Update
Sep 21, 2024
Verified by
Yotam Maman
Missing
video or image, funding rounds, news, markets, not claimed
Team (1)
Ronen Sobel
Co-founder & CEO
Founder
Internal
Created by
Yotam Maman (yotamm1988@gmail.com)
Created
2021-03-24T00:00:00.000Z
Last editor
Yotam Maman (yotamm1988@gmail.com)